NEA Management Company as of Sept. 30, 2025
Portfolio Holdings for NEA Management Company
NEA Management Company holds 29 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Rhythm Pharmaceuticals (RYTM) | 16.1 | $294M | 2.9M | 100.99 | |
| Arcellx Common Stock (ACLX) | 13.7 | $250M | 3.0M | 82.10 | |
| Verona Pharma Sponsered Ads (VRNA) | 13.2 | $240M | 2.3M | 106.71 | |
| Coursera (COUR) | 8.3 | $151M | 13M | 11.71 | |
| Trevi Therapeutics (TRVI) | 6.6 | $121M | 13M | 9.15 | |
| Celcuity (CELC) | 5.8 | $106M | 2.1M | 49.40 | |
| Savara (SVRA) | 4.8 | $87M | 25M | 3.57 | |
| Crispr Therapeutics Namen Akt (CRSP) | 3.8 | $69M | 1.1M | 64.81 | |
| Mbx Biosciences (MBX) | 3.5 | $63M | 3.6M | 17.50 | |
| Zenas Biopharma (ZBIO) | 3.3 | $61M | 2.7M | 22.20 | |
| Monte Rosa Therapeutics (GLUE) | 3.1 | $57M | 7.7M | 7.41 | |
| Korro Bio (KRRO) | 2.9 | $52M | 1.1M | 47.89 | |
| Oric Pharmaceuticals (ORIC) | 2.7 | $49M | 4.1M | 12.00 | |
| Gossamer Bio (GOSS) | 2.6 | $48M | 18M | 2.63 | |
| Aurinia Pharmaceuticals (AUPH) | 2.4 | $44M | 4.0M | 11.05 | |
| Phathom Pharmaceuticals (PHAT) | 1.3 | $23M | 2.0M | 11.77 | |
| Neuehealth Com New | 1.0 | $18M | 2.7M | 6.67 | |
| Black Diamond Therapeutics (BDTX) | 0.9 | $17M | 4.4M | 3.79 | |
| CVRX (CVRX) | 0.9 | $16M | 2.0M | 8.07 | |
| Champions Oncology Com New (CSBR) | 0.6 | $11M | 1.7M | 6.47 | |
| Inventiva Sa Ads (IVA) | 0.5 | $8.3M | 1.5M | 5.69 | |
| Omada Health (OMDA) | 0.4 | $8.1M | 364k | 22.11 | |
| X4 Pharmaceuticals | 0.4 | $7.6M | 2.2M | 3.42 | |
| Nkarta (NKTX) | 0.4 | $7.4M | 3.6M | 2.07 | |
| Senti Biosciences Com New (SNTI) | 0.3 | $5.3M | 3.8M | 1.41 | |
| Synlogic Com New (SYBX) | 0.3 | $4.9M | 2.9M | 1.67 | |
| Marker Therapeutics Com New (MRKR) | 0.1 | $1.5M | 1.6M | 0.89 | |
| Onkure Therapeutics Com Cl A (OKUR) | 0.1 | $1.3M | 479k | 2.75 | |
| Imagenebio | 0.0 | $408k | 50k | 8.15 |
